Article info
PDFReview
Gynecologic cancer surveillance in the era of SARS-CoV-2 (COVID-19)
- Correspondence to Dr Gemma Mancebo, Department of Obstetrics and Gynecology, Hospital del Mar, Universitat Autònoma de Barcelona, Passeig Marítim 25-29, E-08003 Barcelona, Spain; GMancebo{at}parcdesalutmar.cat
Citation
Gynecologic cancer surveillance in the era of SARS-CoV-2 (COVID-19)
Publication history
- Received August 7, 2020
- Revision received September 18, 2020
- Accepted September 21, 2020
- First published October 5, 2020.
Article Versions
- You are currently viewing a Previous version of this article (7 June 2021).
- View the most recent version of this article
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© IGCS and ESGO 2020. No commercial re-use. See rights and permissions. Published by BMJ. This article is made freely available for use in accordance with BMJ’s website terms and conditions for the duration of the covid-19 pandemic or until otherwise determined by BMJ. You may use, download and print the article for any lawful, non-commercial purpose (including text and data mining) provided that all copyright notices and trade marks are retained.https://bmj.com/coronavirus/usage